Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
Physiological Reviews|July 5, 2003
Nongenomic steroid action: controversies, questions, and answersRalf M Losel, Elisabeth Falkenstein, Martin Feuring, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
Nongenomic cardiovascular effects of triiodothyronine in euthyroid male volunteersBernhard M W Schmidt, Nicole Martin, Anette C Georgens, et al.
Cardiovascular Diabetology|February 4, 2015
Treatment-dependent and treatment-independent risk factors associated with the risk of diabetes-related events: a retrospective analysis based on 229,042 patients with type 2 diabetes mellitusThomas Wilke, Sabrina Mueller, Antje Groth, et al.
Steroids|March 1, 2011
Overlapping nongenomic and genomic actions of thyroid hormone and steroidsPaul J Davis, Hung-Yun Lin, Shaker A Mousa, et al.
Molecular and Cellular Endocrinology|April 29, 2008
Expression of progesterone receptor membrane component 1 and its partner serpine 1 mRNA binding protein in uterine and placental tissues of the mouse and humanLing Zhang, Yoshiaki Kanda, Drucilla J Roberts, et al.
European Journal of Clinical Investigation|June 17, 2014
Measurement of rivaroxaban and apixaban in serum samples of patientsJob Harenberg, Sandra Krämer, Shanshan Du, et al.
Plos One|March 20, 2010
N-octanoyl dopamine, a non-hemodyanic dopamine derivative, for cell protection during hypothermic organ preservationRalf M Lösel, Ulf Schnetzke, Paul T Brinkkoetter, et al.
British Journal of Clinical Pharmacology|October 1, 2008
Evaluation of the pharmacokinetics of digoxin in healthy subjects receiving etoricoxibJules I Schwartz, Nancy G B Agrawal, Martin Wehling, et al.
Seminars in Thrombosis and Hemostasis|February 24, 2015
Development of recommendations to continue anticoagulation with one of the two types of oral anticoagulants based on the identification of patients' preferenceShabnam Zolfaghari, Job Harenberg, Lutz Frölich, et al.
Drugs & Aging|May 12, 2017
Appropriateness of Oral Anticoagulants for the Long-Term Treatment of Atrial Fibrillation in Older People: Results of an Evidence-Based Review and International Consensus Validation Process (OAC-FORTA 2016)Martin Wehling, Ronan Collins, Victor M Gil, et al.
Pageof 15